Lidocaine Hydrochloride/Bupivacaine Hydrochloride

盐酸利多卡因/盐酸布比卡因

Report date: 2025/09/26 16:39:25

Base Information

Drug NameLidocaine Hydrochloride/Bupivacaine Hydrochloride
Drug Alias NameBupivacaine Hydrochloride/Lidocaine Hydrochloride盐酸布比卡因盐酸利多卡因Bupivacaine Hydrochloride and Lidocaine Hydrochloride盐酸利多卡因盐酸布比卡因Lidocaine/Bupivacaine +[6] 
ClassificationSmall molecules
Mechanisms of ActionSodium channel alpha subunit blockersSodium channels blockers
TargetsSodium channelsSodium channel alpha subunit
Therapy Area/IndicationsAnesthesia
Global Approved IndicationsAnesthesia
Approved Indications in ChinaAnesthesia
Original Approved Country/TerritoryUnited States
Original Approved Date2003/05/23
Country/TerritoryUnited StatesMainland China
CombinationsYes Lidocaine HydrochlorideBupivacaine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAmphastar
China Registration ClassN/A

Develop Information

Active CompaniesJiangxi Qingfeng Pharmaceutical Industry Co Ltd
Inactive CompaniesAmphastar Pharmaceuticals Inc
Active IndicationsAnesthesia
Inactive IndicationsN/A

Other Information

ATC CodeN01BB51N01BB52
Related LinksN/A